Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria.<ref name=AHFS2015></ref> When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure.<ref name=AHFS2015/> It can be used to treat mild or moderate malaria but is not recommended for severe malaria.<ref name=AHFS2015/> It is taken by mouth.<ref name=AHFS2015/>
Common side effects include vomiting, diarrhea, headaches, sleep disorders, and a rash.<ref name=AHFS2015/> Serious side effects include potentially long-term mental health problems such as depression, hallucinations, and anxiety and neurological side effects such as Ataxia, seizures, and tinnitus.<ref name=AHFS2015/> It is therefore not recommended in people with a history of mental health problems or epilepsy.<ref name=AHFS2015/> It appears to be safe during pregnancy and breastfeeding.<ref name="Drugs.com pregnancy"></ref>
Mefloquine was developed by the United States Army in the 1970s and came into use in the mid 1980s.<ref name=Croft07></ref><ref></ref><ref></ref> It is on the WHO Model List of Essential Medicines.<ref name="WHO21st"></ref> It is available as a generic medication.<ref name=AHFS2015/>